KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EBT: 2009-2024

Historic EBT for Thermo Fisher Scientific (TMO) over the last 16 years, with Dec 2024 value amounting to $7.0 billion.

  • Thermo Fisher Scientific's EBT rose 4.82% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 billion, marking a year-over-year increase of 3.80%. This contributed to the annual value of $7.0 billion for FY2024, which is 11.73% up from last year.
  • As of FY2024, Thermo Fisher Scientific's EBT stood at $7.0 billion, which was up 11.73% from $6.3 billion recorded in FY2023.
  • In the past 5 years, Thermo Fisher Scientific's EBT registered a high of $8.8 billion during FY2021, and its lowest value of $6.3 billion during FY2023.
  • In the last 3 years, Thermo Fisher Scientific's EBT had a median value of $7.0 billion in 2024 and averaged $7.1 billion.
  • Per our database at Business Quant, Thermo Fisher Scientific's EBT soared by 77.55% in 2020 and then fell by 19.62% in 2023.
  • Yearly analysis of 5 years shows Thermo Fisher Scientific's EBT stood at $7.2 billion in 2020, then increased by 22.28% to $8.8 billion in 2021, then dropped by 11.38% to $7.8 billion in 2022, then dropped by 19.62% to $6.3 billion in 2023, then increased by 11.73% to $7.0 billion in 2024.